Stamford, CT -- (SBWIRE) -- 12/02/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: International Stem Cell Corp(OTCMKTS:ISCO), Formcap Corp(OTCMKTS:FRMC), THEDIRECTORY.COM INC(OTCMKTS:SEEK), Adamis Pharmaceuticals Corp(OTCMKTS:ADMP)
International Stem Cell Corp(OTCMKTS:ISCO) managed to keep its gain at 1.08% on below-normal volume of 112,638.00 shares. The stock is at $0.168, floating in a range of $0.16 - 0.17. Its latest price has reached market capitalization of $22.25M. Its 52-week range has been $0.13 - 0.41. International Stem Cell Corporation is a developmental-stage biotechnology company.
Is ISCO a Solid Investment at These Levels? Just Go Here and Find Out
Formcap Corp(OTCMKTS:FRMC) trading on a volume of 162,900.00 shares, lower than its standard daily volume. Shares are at $0.850. Over the last twelve months, the stock has gained 2025% and faced a worst price of $0.01. FormCap Corp. (FormCap) is an exploration-stage company.
Is FRMC a Solid Investment at These Levels? Read This Report for Details
THEDIRECTORY.COM INC(OTCMKTS:SEEK) is up at $0.0034 on below- normal volume of 9.76M shares during the recent trading session. The stock has its 12-month range $ 0.00 - 0.01. It traded in a range of $ 0.00 - 0.00 during the recent trading session.
Is SEEK a Solid Investment at These Levels? Just Go Here and Find Out
In the recent trading session, Adamis Pharmaceuticals Corp(OTCMKTS:ADMP) is on low volume, trading at a volume of versus its average daily volume ratio 96,141.00/157,007.00 shares. At $0.400, the stock has attained market capitalization of 43.52M. Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc.operates through its wholly owned subsidiaries Cellegy Holdings, Inc.
Will Investors Buy ADMP After Reading This News? Just Go Here and Find Out
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at:http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)